Armando E. Acevedo

Pediatrics
2400 NW 54th St
Miami, FL 33142

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants.

A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants.

Journal: The Journal of infectious diseases
Published: July 11, 2024
Showing 1-1 of 1

Last Updated: 09/26/2026